Oncology

Oncology

Biology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways Oncology
21-40 of 65 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.131013.2
Research Article metrics
Revised
Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach
[version 2; peer review: 3 approved]
Abeer M Al-Subaie, Balu Kamaraj, Fazil Ahmad, Khaldoon Alsamman
Peer Reviewers Dicson Sheeja Malar; Gurudeeban Selvaraj; Rajasekaran R.
  • Funder
  • This work was primarily supported by grants from the Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
LATEST VERSION PUBLISHED 18 Jun 2024
https://doi.org/10.12688/f1000research.134992.3
Systematic Review metrics
Revised
Association between eNOS rs1799983 (894G>T) Polymorphism with Cancer and Stroke Risk: A meta-analysis
[version 3; peer review: 1 approved with reservations, 3 not approved]
Abdul Rohim Tualeka, Juliana Jalaludin, Janvier Gasana, Nor Ashikin Sopian, How Ran Chao, Mohd Yusmaidie, Velu Perumal, Suardi Zurimi, Pudji Rahmawati, Ahsan Ahsan, Salsabila Novianti
Peer Reviewers Eric Tzyy Jiann Chong; Katrina Miranda; Mirza Saqib Baig; Saori Furuta
  • Funder
  • Lembaga Penelitian dan Inovasi Universitas Airlangga
LATEST VERSION PUBLISHED 10 Jun 2024
https://doi.org/10.12688/f1000research.132627.3
Research Article metrics
Revised
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Matt Sherwood, Yilu Zhou, Yi Sui, Yihua Wang, Paul Skipp, Carolini Kaid, Juliet Gray, Keith Okamoto, Rob M. Ewing
Peer Reviewers Griffith D Parks; Estanislao Nistal-Villan and Vicent Tur-Planells; Thomas C. N. Leung; Monica Martinez Pacheco
  • Funders
  • Rosetrees Trust
  • Neuroblastoma UK
  • Medical Research Council
  • Children's Cancer and Leukaemia Group
  • Wessex Medical Research
LATEST VERSION PUBLISHED 21 May 2024
https://doi.org/10.12688/f1000research.126721.2
Research Article metrics
Revised
Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker
[version 2; peer review: 1 approved, 2 approved with reservations]
Darawan Rinchai, Damien Chaussabel
Peer Reviewers Mattia Lauriola; Ritu Pandey and Daruka Mahadevan; Akila Prashant and Deepthi V
LATEST VERSION PUBLISHED 04 Apr 2024
https://doi.org/10.12688/f1000research.110072.4
Research Article metrics
Revised
In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer
[version 4; peer review: 3 approved]
Mohammed J. AL-Zobaidy, Hany Akeel Al-Hussaniy, Zahraa S. Al-tameemi
Peer Reviewers Zarrin Basharat; Ahmed A J Mahmood; Mahmoud A. Al-Sha'er
  • Funder
  • The author(s) declared that no grants were involved in supporting this work.
LATEST VERSION PUBLISHED 11 Jan 2024
https://doi.org/10.12688/f1000research.136362.1
Research Article metrics AWAITING PEER REVIEW
Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam
[version 1; peer review: awaiting peer review]
Siti Nur Idayu Matusin, Zen Huat Lu, Mas Rina Wati Haji Abdul Hamid
Peer Reviewers Invited
  • Funder
  • Universiti Brunei Darussalam
PUBLISHED 30 Nov 2023
https://doi.org/10.12688/f1000research.131688.1
Review metrics
Targeting KRAS mutation in gastrointestinal cancers
[version 1; peer review: 2 approved with reservations]
Fuat Bicer, Mehmet Akce, Gary Piazza, Jeremy Foote, Bassel El-Rayes
Peer Reviewers Maria Diab; Jing Lu
  • Funder
  • National Institutes of Health
PUBLISHED 13 Nov 2023
https://doi.org/10.12688/f1000research.127368.2
Review metrics
Revised
Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers
[version 2; peer review: 2 approved, 1 approved with reservations]
Monica Charlotte Solomon, Chetana Chandrashekar, Spoorti Kulkarni, Nisha Shetty, Aditi Pandey
Peer Reviewers John W Barrett; Ajaz Bhat; Jiji George
LATEST VERSION PUBLISHED 04 Oct 2023
https://doi.org/10.12688/f1000research.125272.2
Research Article metrics
Revised
Circadian disruption does not alter tumorigenesis in a mouse model of lymphoma
[version 2; peer review: 2 approved]
Rebecca M Mello, Marie Pariollaud, Katja A Lamia
Peer Reviewers Chi Van Dang; Eric Zhang
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 28 Sep 2023
https://doi.org/10.12688/f1000research.130316.1
Research Article metrics
Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Israa Shihab, Amal Bouzid, Burcu Yener, Alaa Altaie, Poorna Manasa Bhamidimarri, Mouza Al Ameri, Riyad Bendardaf, Mawieh Hamad, Rifat Hamoudi
Peer Reviewers Aamir Ahmed; Wenbin Zhou; Claudia Lanari and Andrés Elia
  • Funders
  • Al-Jalila Foundation
  • ASPIRE Precision Medicine Research Institute Abu Dhabi
PUBLISHED 08 Sep 2023
https://doi.org/10.12688/f1000research.122408.2
Research Article metrics
Revised
Methylene blue sentinel lymph node biopsy for breast cancer learning curve in the COVID-19 era: How many cases are enough?
[version 2; peer review: 2 approved]
Yohana Azhar, Birgitta M. Dewayani, Kiki Lukman
Peer Reviewers Dedy Hermansyah; Tony Mallett and Owen Ung
LATEST VERSION PUBLISHED 29 Aug 2023
https://doi.org/10.12688/f1000research.113303.2
Research Article metrics
Revised
The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
[version 2; peer review: 2 approved]
Noni Novisari Soeroso, Fannie Rizki Ananda, Johan Samuel Sitanggang, Noverita Sprinse Vinolina
Peer Reviewers Fariz Nurwidya; Darren Wan-Teck Lim
LATEST VERSION PUBLISHED 15 Jun 2023
https://doi.org/10.12688/f1000research.128716.2
Review metrics
Revised
Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer
[version 2; peer review: 2 approved]
Bridget M. Fortin, Alisa L. Mahieu, Rachel C. Fellows, Nicholas R. Pannunzio, Selma Masri
Peer Reviewers Phillip Karpowicz; Kristin Eckel-Mahan
  • Funders
  • American Cancer Society
  • National Institutes of Health
  • Johnson and Johnson
  • V Foundation for Cancer Research
LATEST VERSION PUBLISHED 16 May 2023
https://doi.org/10.12688/f1000research.122987.2
Brief Report metrics
Revised
Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism
[version 2; peer review: 2 approved]
Colin J. Henderson, Aileen W. McLaren, Yury Kapelyukh, C. Roland Wolf
Peer Reviewers Russ Prough; Chris Goldring
  • Funders
  • Cancer Research UK
  • Medical Research Council
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 27 Mar 2023
https://doi.org/10.12688/f1000research.129860.2
Research Article metrics
Revised
Ocimum sanctum Linn. Ethanolic extract promotes an antiproliferative and apoptosis activity in MCF-7 and T47D breast cancer cell lines mediated by upregulation of ROS/RNS, Caspase 9, and Caspase 3: an in silico and in vitro study
[version 2; peer review: 1 approved, 1 not approved]
Hevi Wihadmadyatami, Srikanth Karnati, Suleyman Ergún, Ulayatul Kustiati, Dewi Ratih Tirtosari, Dwi Liliek Kusindarta, Yudy Tjahjono
Peer Reviewers Muhammad Lokman MD Isa; Stéphanie Grandemange
LATEST VERSION PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.109136.2
Research Article metrics
Revised
Genomic profiles of Indonesian colorectal cancer patients
[version 2; peer review: 2 approved]
Murdani Abdullah, Sofy Meilany, Hidayat Trimarsanto, Safarina G. Malik, Ninik Sukartini, Firhat Idrus, Saskia A. Nursyirwan, Virly N. Muzellina, Rabbinu R. Pribadi, Amanda P. Utari, Hasan Maulahela, Ari F. Syam
Peer Reviewers Ahmad Rusdan Handoyo Utomo; Wei Zhang
  • Funder
  • Indonesian Ministry of Research, Technology, and Higher Education through the World Class Research (WCR) 2019 Program
LATEST VERSION PUBLISHED 21 Feb 2023
https://doi.org/10.12688/f1000research.129490.1
Research Article metrics
Toblerone: detecting exon deletion events in cancer using RNA-seq
[version 1; peer review: 2 approved]
Andrew Lonsdale, Andreas Halman, Lauren Brown, Hansen Kosasih, Paul Ekert, Alicia Oshlack
Peer Reviewers Katherine Pillman; Matt Field
  • Funder
  • National Health and Medical Research Council
PUBLISHED 03 Feb 2023
https://doi.org/10.12688/f1000research.129089.1
Opinion Article metrics
Genetic evolution and cellular interactions within the tumour microenvironment determine glioblastoma progression
[version 1; peer review: 1 approved]
Chloe Shard, Kimberley L. Alexander, Hui K. Gan, Guillermo A. Gomez
Peer Reviewers Dinorah Friedmann-Morvinski
  • Funders
  • Mark Hughes Foundation
  • James N Kirby Foundation
  • BF Foundation
  • Cure Brain Cancer Foundation
  • Charlie Teo Foundation
  • National Health and Medical Research Council
  • Neurosurgical Research Foundation
  • BrainStorm Brain Cancer Research
PUBLISHED 13 Jan 2023
https://doi.org/10.12688/f1000research.110903.2
Software Tool Article metrics
Revised
SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery
[version 2; peer review: 2 approved]
Bahar Tercan, Guangrong Qin, Taek-Kyun Kim, Boris Aguilar, John Phan, William Longabaugh, David Pot, Christopher J. Kemp, Nyasha Chambwe, Ilya Shmulevich
Peer Reviewers Jane Usher; Nishanth Ulhas Nair
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 22 Dec 2022
https://doi.org/10.12688/f1000research.129084.1
Research Article metrics AWAITING PEER REVIEW
Three-dimensional wavelet decomposition-based radiomics analysis for tumor characterization in patients with oropharyngeal squamous cell carcinoma
[version 1; peer review: awaiting peer review]
Hassan Bagher-Ebadian, Farzan Siddiqui, Ahmed I. Ghanem, Benjamin Movsas, Indrin J. Chetty
Peer Reviewers Invited
  • Funder
  • Varian Medical Systems
PUBLISHED 21 Dec 2022
21-40 of 65 ARTICLES
Previous Next
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.